Abreos is dedicated to improving the development and commercialization of biopharmaceuticals with our proprietary Veritope platform.
Abreos Biosciences is a privately owned, San Diego-based biotechnology company developing integrated pharmaceuticals for oncology, neurology and autoimmune disease. Our proprietary VeritopeTM platform is comprised of mimetope peptides that can bind to monoclonal antibodies and other biologic drugs.
Built upon research from the Moores Cancer Center at UC San Diego by Abreos Founder Bradley Messmer PhD, the VeritopeTM technology has been validated by six major pharma partners in applications to create:
– Faster and more robust clinical assays
– Improved purification methods
– Improved Clinical PK Studies
– Novel PK/PD approaches to monitor biologic drugs
Abreos Biosciences currently has one commercially available laboratory developed test and a leading therapeutic asset in neurological disease.
P: 858 203 1168
E: [email protected]